Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Basik

Showing results (101-110 of 130) with videos related to

Pageof 13
Sort By:
Genes|January 23, 2024
The Mutational Spectrum of Pre- and Post-Neoadjuvant Chemotherapy Triple-Negative Breast CancersAdriana Aguilar-Mahecha, Najmeh Alirezaie, Josiane Lafleur, et al.
Breast Cancer Research : BCR|March 13, 2025
Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysisDiana Zhang, Shayesteh Jahanfar, Judy B Rabinowitz, et al.
Scientific Reports|September 8, 2020
Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancerLuca Cavallone, Adriana Aguilar-Mahecha, Josiane Lafleur, et al.
BMC Medical Genomics|October 29, 2011
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell linesKevin C H Ha, Emilie Lalonde, Lili Li, et al.
The Oncologist|April 6, 2022
"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome ManagementSalma Shickh, Leslie E Oldfield, Marc Clausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJean-Francois Boileau, Brigitte Poirier, Mark Basik, et al.
American Journal of Human Genetics|October 6, 2023
Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsyKirsten M Farncombe, Derek Wong, Maia L Norman, et al.
Cell Reports|November 2, 2017
A Targetable EGFR-Dependent Tumor-Initiating Program in Breast CancerPaul Savage, Alexis Blanchet-Cohen, Timothée Revil, et al.
Scientific Reports|September 7, 2017
Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baitsMiguel Alcaide, Stephen Yu, Jordan Davidson, et al.
Breast Cancer : Basic and Clinical Research|December 4, 2025
Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World SettingKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Pageof 13

Showing results (101-110 of 130) with videos related to

Sort By:
Pageof 13
Genes|January 23, 2024
The Mutational Spectrum of Pre- and Post-Neoadjuvant Chemotherapy Triple-Negative Breast CancersAdriana Aguilar-Mahecha, Najmeh Alirezaie, Josiane Lafleur, et al.
Breast Cancer Research : BCR|March 13, 2025
Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysisDiana Zhang, Shayesteh Jahanfar, Judy B Rabinowitz, et al.
Scientific Reports|September 8, 2020
Prognostic and predictive value of circulating tumor DNA during neoadjuvant chemotherapy for triple negative breast cancerLuca Cavallone, Adriana Aguilar-Mahecha, Josiane Lafleur, et al.
BMC Medical Genomics|October 29, 2011
Identification of gene fusion transcripts by transcriptome sequencing in BRCA1-mutated breast cancers and cell linesKevin C H Ha, Emilie Lalonde, Lili Li, et al.
The Oncologist|April 6, 2022
"Game Changer": Health Professionals' Views on the Clinical Utility of Circulating Tumor DNA Testing in Hereditary Cancer Syndrome ManagementSalma Shickh, Leslie E Oldfield, Marc Clausen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 3, 2014
Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC studyJean-Francois Boileau, Brigitte Poirier, Mark Basik, et al.
American Journal of Human Genetics|October 6, 2023
Current and new frontiers in hereditary cancer surveillance: Opportunities for liquid biopsyKirsten M Farncombe, Derek Wong, Maia L Norman, et al.
Cell Reports|November 2, 2017
A Targetable EGFR-Dependent Tumor-Initiating Program in Breast CancerPaul Savage, Alexis Blanchet-Cohen, Timothée Revil, et al.
Scientific Reports|September 7, 2017
Targeted error-suppressed quantification of circulating tumor DNA using semi-degenerate barcoded adapters and biotinylated baitsMiguel Alcaide, Stephen Yu, Jordan Davidson, et al.
Breast Cancer : Basic and Clinical Research|December 4, 2025
Evaluation of Recurrence Rate in Canadian Patients With Stage II/III HR+/HER2- Early Breast Cancer in the Real-World SettingKaren Gambaro, Kahina Rachedi, Mark Basik, et al.
Pageof 13